Together, these results suggest that IRF4 plays a role in subverting multiple immune surveillance mechanisms by the transcriptional control of related genes, including PD-L1 and PD1, and cGAS and STING, in the context of oncogenic viral infection that is associated with blood cancers. Here, IRF4 is linked to hematopoietic and lymphoid system neoplasm.